Hadjidemetriou M - Search Results

1

The lipidomic profile of the nanoparticle-biomolecule corona reflects the diversity of plasma lipids.

Papafilippou L, Nicolaou A, Kendall AC, Camacho-Muñoz D, Hadjidemetriou M. Papafilippou L, et al. Among authors: hadjidemetriou m. Nanoscale. 2023 Jul 6;15(26):11038-11051. doi: 10.1039/d2nr05982g. Nanoscale. 2023. PMID: 37357917

2

Protein corona fingerprinting to differentiate sepsis from non-infectious systemic inflammation.

Papafilippou L , Claxton A , Dark P , Kostarelos K , Hadjidemetriou M . Papafilippou L , et al. Among authors: hadjidemetriou m. Nanoscale. 2020 May 14;12(18):10240-10253. doi: 10.1039/d0nr02788j. Nanoscale. 2020. PMID: 32356537

3

Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer's Disease.

Hadjidemetriou M, Rivers-Auty J, Papafilippou L, Eales J, Kellett KAB, Hooper NM, Lawrence CB, Kostarelos K. Hadjidemetriou M, et al. ACS Nano. 2021 Apr 27;15(4):7357-7369. doi: 10.1021/acsnano.1c00658. Epub 2021 Mar 17. ACS Nano. 2021. PMID: 33730479 Free PMC article.

4

The challenge of recognising sepsis: Future nanotechnology solutions.

Claxton A, Papafilippou L, Hadjidemetriou M, Kostarelos K, Dark P. Claxton A, et al. Among authors: hadjidemetriou m. J Intensive Care Soc. 2020 Aug;21(3):241-246. doi: 10.1177/1751143719896554. Epub 2019 Dec 18. J Intensive Care Soc. 2020. PMID: 32782464 Free PMC article. Review.

5

Nanotools for Sepsis Diagnosis and Treatment.

Papafilippou L, Claxton A, Dark P, Kostarelos K, Hadjidemetriou M. Papafilippou L, et al. Among authors: hadjidemetriou m. Adv Healthc Mater. 2021 Jan;10(1):e2001378. doi: 10.1002/adhm.202001378. Epub 2020 Nov 25. Adv Healthc Mater. 2021. PMID: 33236524 Free PMC article. Review.

6

The biomolecule corona of lipid nanoparticles contains circulating cell-free DNA.

Gardner L, Warrington J, Rogan J, Rothwell DG, Brady G, Dive C, Kostarelos K, Hadjidemetriou M. Gardner L, et al. Among authors: hadjidemetriou m. Nanoscale Horiz. 2020 Nov 1;5(11):1476-1486. doi: 10.1039/d0nh00333f. Epub 2020 Aug 27. Nanoscale Horiz. 2020. PMID: 32853302

7

Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles.

Hadjidemetriou M, Al-Ahmady Z, Kostarelos K. Hadjidemetriou M, et al. Nanoscale. 2016 Apr 7;8(13):6948-57. doi: 10.1039/c5nr09158f. Epub 2016 Mar 10. Nanoscale. 2016. PMID: 26961355

8

In vivo formation of protein corona on gold nanoparticles. The effect of their size and shape.

García-Álvarez R , Hadjidemetriou M , Sánchez-Iglesias A , Liz-Marzán LM , Kostarelos K . García-Álvarez R , et al. Among authors: hadjidemetriou m. Nanoscale. 2018 Jan 18;10(3):1256-1264. doi: 10.1039/c7nr08322j. Nanoscale. 2018. PMID: 29292433

9

The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study.

Hadjidemetriou M, McAdam S, Garner G, Thackeray C, Knight D, Smith D, Al-Ahmady Z, Mazza M, Rogan J, Clamp A, Kostarelos K. Hadjidemetriou M, et al. Adv Mater. 2019 Jan;31(4):e1803335. doi: 10.1002/adma.201803335. Epub 2018 Nov 28. Adv Mater. 2019. PMID: 30488990

10

A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona.

Hadjidemetriou M, Al-Ahmady Z, Buggio M, Swift J, Kostarelos K. Hadjidemetriou M, et al. Biomaterials. 2019 Jan;188:118-129. doi: 10.1016/j.biomaterials.2018.10.011. Epub 2018 Oct 13. Biomaterials. 2019. PMID: 30343255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters